تخطي إلى المحتوى الرئيسي

Superficial thrombophlebitis

المهنيين الطبيين

تم تصميم مقالات المراجع المهنية لاستخدامها من قبل المتخصصين في الرعاية الصحية. يتم كتابتها بواسطة أطباء من المملكة المتحدة وتستند إلى أدلة بحثية وإرشادات المملكة المتحدة وأوروبا. قد تجد Superficial thrombophlebitis مقالة أكثر فائدة، أو واحدة من مقالاتنا الأخرى مقالاتنا الصحية.

تابع القراءة أدناه

What is superficial thrombophlebitis?

Superficial thrombophlebitis occurs when a superficial vein (usually the long saphenous vein of the leg or its tributaries) becomes inflamed and the blood within it clots. It may be spontaneous or associated with one or more risk factors - eg, varicose veins.

It is usually a benign self-limiting disease but it can be difficult to treat and slow to resolve.

This is a very common condition and, although figures are difficult to find. Some reports estimate an incidence of between 3-11% of the general population.1

It has a female preponderance, and seasonal variation (more common in warmer months) has also been reported. Women make up 50-70% of reported cases of superficial venous thrombophlebitis.23

Risk factors for superficial thrombophlebitis1

The three cardinal risk factors for deep vein thrombosis (Virchow's triad) are:

  • Damage to the blood vessel wall (as a result of trauma, infection, or inflammation), including الدوالي.

  • Stasis of blood flow.

  • Hypercoagulability of blood.

These are also thought to be risk factors for superficial venous thrombophlebitis but the relevance of hypercoagulability has been questioned. 2

Other specific risk factors include:

  • Obesity.

  • Thrombophilia.

  • Previous history of superficial vein thrombosis.

  • Previous history of deep vein thrombosis or pulmonary embolism. 2

  • التدخين.

  • Oral contraceptives.

  • الحمل.4

  • Intravenous drug abuse.

  • Intravenous infusion (especially if an irritant substance was infused).5

  • Varicose veins.

تابع القراءة أدناه

There are various different presentations of superficial thrombophlebitis:

  • Superficial thrombophlebitis usually occurs in the lower extremities but occurs also in the penis and the breast (Mondor's disease).6

  • Traumatic thrombophlebitis follows an injury. There is a tender cord along the course of a vein and bruising.

  • Thrombophlebitis frequently occurs with an intravenous cannula. Either the cannula or the infusion, including drugs, may have caused the inflammation. A small lump may appear days or weeks after the cannula has been removed and it can take months to resolve completely. The common sites coincide with those of common medical interventions (arm or neck with external jugular vein cannulation).

  • Iatrogenic chemical phlebitis is deliberately produced by sclerotherapy.

  • Thrombophlebitis in a varicose vein develops as a tender hard knot in the vein. There is often erythema, and bleeding may occur as the reaction extends through the vein wall. It is common with venous stasis ulcers.

  • Septic phlebitis usually occurs with long-term use of an intravenous cannula. It is also common in intravenous drug abusers who use dirty equipment and have poor technique.

  • Suppurative thrombophlebitis is a serious complication when there is pus in the vein and septicaemia may develop.7

  • Thrombosis of a haemorrhoid or perianal haematoma is a superficial thrombophlebitis. Incision and removal of the thrombus relieves the condition.

علامات

  • There is redness with tenderness along the vein with swelling.

  • Spontaneous thrombophlebitis usually develops in the greater saphenous vein, often with varicose veins.

تابع القراءة أدناه

  • Further investigation may be warranted to assess for an underlying DVT.8

  • If a septic cannula is suspected, it should be removed and sent for culture.

  • Recurrent thromboses in superficial veins at various sites are called migratory thrombophlebitis. This is a pointer for malignancy, especially carcinoma of the tail of pancreas.9 10

  • Phlebitis occurs in diseases associated with vasculitis, such as polyarteritis nodosa و Buerger's disease, which Buerger reported in 1909.

إجراءات عامة

  • Elastic support of the limb reduces swelling and eases discomfort.

  • Severe thrombophlebitis does not usually require bed rest unless there is severe pain on movement. The affected extremity should be elevated if possible and large, warm compresses may be applied, although the evidence base for their effectiveness is limited and care must be taken to avoid burning the patient.11

  • Exercise reduces pain and the possibility of DVT. Only in cases in which pain is very severe is bed rest necessary. DVT prophylaxis should be established in patients with reduced mobility.12

  • Keeping the leg elevated when sitting may improve venous blood flow and reduce swelling.

دوائي

  • Topical anti-inflammatory creams applied locally to the superficial vein thrombosis/superficial thrombophlebitis area controls mild symptoms.

  • Otherwise an oral non-steroidal anti-inflammatory drug (NSAID) and/or paracetamol will be required for pain relief.

  • Topical heparin has been shown to have some limited benefit in treating superficial venous thrombosis but studies have been poor. 13

  • Low molecular weight heparin (LMWH) and fondaparinux have been shown to reduce the risk of superficial vein thrombosis extension and recurrence.

  • Prophylactic fondaparinux given for 45 days appears to be an effective option for superficial thrombophlebitis for most people.14

  • A Cochrane review in 2018 suggests that 45 days of subcutaneous fondaparinux should be offered to all patients with:

    • A superficial thrombophlebitis extending more than 5cm in length.

    • A superficial thrombophlebitis proximal to the knee, particularly within 10cm of the saphenofemoral junction.

    • Severe symptoms.

    • Greater saphenous vein involvement.

    • Previous VTE or previous superficial thrombophlebitis.

    • Active malignancy.

    • Recent surgery.15

  • Fondaparinux significantly reduces the risk of symptomatic venous thromboembolism and may be considered in people at increased risk of a DVT or PE - eg, those with superficial thrombus near the saphenofemoral junction.

Antibiotics are only required if there is evidence of infection.

جراحي

If there are recurrences of the thrombophlebitis associated with extensive varicose veins, they should be excised.

  • Extension into the deep veins, with possible development of deep vein thrombosis and/or انسداد رئوي (PE).16 17

  • Damage to valves may lead to varicose veins.

  • Suppurative phlebitis can lead to metastatic abscesses and septicaemia.

  • Hyperpigmentation over the vein.

  • Persistent firm nodule in subcutaneous tissues at the affected site.

  • The prognosis is usually good for uncomplicated superficial thrombophlebitis. Symptoms generally subside in 1-2 weeks. Hardness of the vein may persist for several weeks to months.

  • The risk of recurrence ranges between 1.6-12.2% in treated cases and 3.3-36.7% in untreated cases, depending on the presence or absence of underlying risk factors.

  • It rarely leads to PE, although it can occur if the process extends into a deep vein.

  • People with superficial venous thrombosis do not seem predisposed to develop DVT but superficial venous thrombosis does frequently occur in association with DVT, especially with stasis ulceration around the ankle.

  • Where venous thromboembolism precedes thrombophlebitis, there is an increased risk of recurrent VTE.18

تحديثات حصرية لمتخصصي الرعاية الصحية

ابقَ على اطلاع بأحدث التحديثات السريرية، والرؤى المهنية، والإرشادات المستندة إلى الأدلة. تقوم نشرة Patient Pro الإخبارية بتجميع محتوى أساسي لمتخصصي الرعاية الصحية - يتم تسليمه مباشرة إلى بريدك الوارد.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

قراءة إضافية ومراجع

  1. Superficial vein thrombosis (superficial thrombophlebitis); NICE CKS; March 2020 (UK access only)
  2. Mangiafico M, Costanzo L; Superficial Venous Thrombosis: A Comprehensive Review. Healthcare (Basel). 2024 Feb 19;12(4):500. doi: 10.3390/healthcare12040500.
  3. Kakkos SK, Lampropoulos G, Papadoulas S, et al; Seasonal variation in the incidence of superficial venous thrombophlebitis. Thromb Res. 2010 Aug;126(2):98-102.
  4. Kupelian AS, Huda MS; Pregnancy, thrombophlebitis and thromboembolism: what every obstetrician should know. Arch Gynecol Obstet. 2007 Mar;275(3):215-7. Epub 2006 Aug 10.
  5. Eyigor C, Ceylan A, Demir F, et al; Superficial venous thrombophlebitis caused by rocuronium. J Anesth. 2010 Aug;24(4):646-8. Epub 2010 Apr 22.
  6. Laroche JP, Galanaud J, Labau D, et al; Mondor's disease: what's new since 1939? Thromb Res. 2012 Oct;130 Suppl 1:S56-8. doi: 10.1016/j.thromres.2012.08.276.
  7. Chirinos JA, Garcia J, Alcaide ML, et al; Septic thrombophlebitis: diagnosis and management. Am J Cardiovasc Drugs. 2006;6(1):9-14.
  8. Guidelines on the investigation and management of venous thrombosis at unusual sites; British Journal of Haematology
  9. Diaconu C, Mateescu D, Balaceanu A, et al; Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report. J Med Life. 2010 Jan-Mar;3(1):96-9.
  10. Recurrent thromboflebitis as a warning sign for cancer: a case report. van Weert HC, Pingen F; Cases J. 2009 Oct 13;2:153.
  11. Litzendorf ME, Satiani B; Superficial venous thrombosis: disease progression and evolving treatment approaches. Vasc Health Risk Manag. 2011;7:569-75. doi: 10.2147/VHRM.S15562. Epub 2011 Aug 31.
  12. Cesarone MR, Belcaro G, Agus G, et al; Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. Angiology. 2007 Apr-May;58 Suppl 1:7S-14S; discussion 14S-15S.
  13. Vecchio C, Frisinghelli A; Topically applied heparins for the treatment of vascular disorders : a comprehensive review. Clin Drug Investig. 2008;28(10):603-14. doi: 10.2165/00044011-200828100-00001.
  14. Di Nisio M, Wichers IM, Middeldorp S; Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2018 Feb 25;2:CD004982. doi: 10.1002/14651858.CD004982.pub6.
  15. Czysz A, Higbee SL; Superficial Thrombophlebitis.
  16. Dewar C, Panpher S; Incidence of deep vein thrombosis in patients diagnosed with superficial thrombophlebitis after presenting to an emergency department outpatient deep vein thrombosis service. Emerg Med J. 2010 Oct;27(10):758-61. Epub 2010 Jun 17.
  17. Decousus H, Quere I, Presles E, et al; Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010 Feb 16;152(4):218-24.
  18. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. Schonauer V, Kyrle PA, Weltermann A, et al; J Vasc Surg. 2003 Apr;37(4):834-8.

تابع القراءة أدناه

عن المؤلفعرض السيرة الذاتية الكاملة

صورة المؤلف

الدكتورة فيليبا فينسنت، MRCGP

طبيب عام، مؤلف طبي

MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG

الدكتورة فيليبا Vincent is an NHS GP working in North London.

حول المراجععرض السيرة الذاتية الكاملة

صورة المؤلف

الدكتور دوغ مكيتشني، MRCGP

Medical Writer

MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA

الدكتور دوغ مكيتشني هو طبيب عام في هيئة الخدمات الصحية الوطنية يعمل في لندن. يعمل بدوام كامل في المجال السريري وهو أيضًا نائب رئيس وحدة الممارسة السريرية والمهنية في كلية الطب بجامعة كوليدج لندن.

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.

أداة التحقق من أهلية لقاح الإنفلونزا

اسأل، شارك، تواصل.

تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.

مدقق الأعراض

هل تشعر بتوعك؟

قم بتقييم أعراضك عبر الإنترنت مجانًا